Evidence map›Paper›PMID 35481198›Full record

ArticleRSC advances2021

Resin-supported iridium complex for low-temperature vanillin hydrogenation using formic acid in water.

Christene A Smith, Francesco Brandi, Majd Al-Naji, Ryan Guterman

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christene A SmithDepartment of Colloid Chemistry, Max Planck Institute of Colloids and Interfaces Am Mühlenberg 1 14476 Potsdam Germany Ryan.guterman@mpikg.mpg.de.
Francesco BrandiDepartment of Colloid Chemistry, Max Planck Institute of Colloids and Interfaces Am Mühlenberg 1 14476 Potsdam Germany Ryan.guterman@mpikg.mpg.de.ORCID https://orcid.org/0000-0002-6765-6755
Majd Al-NajiDepartment of Colloid Chemistry, Max Planck Institute of Colloids and Interfaces Am Mühlenberg 1 14476 Potsdam Germany Ryan.guterman@mpikg.mpg.de.ORCID https://orcid.org/0000-0001-5024-0449
Ryan GutermanDepartment of Colloid Chemistry, Max Planck Institute of Colloids and Interfaces Am Mühlenberg 1 14476 Potsdam Germany Ryan.guterman@mpikg.mpg.de.ORCID https://orcid.org/0000-0003-3231-6176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biorefinery seeks to utilize biomass waste streams as a source of chemical precursors with which to feed the chemical industry. This goal seeks to replace petroleum as the main feedstock, however this task requires the development of efficient catalysts capable of transforming substances derived from biomass into useful chemical products. In this study, we demonstrate that a highly-active iridium complex can be solid-supported and used as a low-temperature catalyst for both the decomposition of formic acid (FA) to produce hydrogen, and as a hydrogenation catalyst to produce vanillyl alcohol (VA) and 2-methoxy-4-methylphenol (MMP) from vanillin (V); a lignin-derived feedstock. These hydrogenation products are promising precursors for epoxy resins and thus demonstrate an approach for their production without the need for petroleum. In contrast to other catalysts that require temperatures exceeding 100 °C, here we accomplish this at a temperature of <50 °C in water under autogenous pressure. This approach provides an avenue towards biorefinery with lower energy demands, which is central to the decentralization and broad implementation. We found that the high activity of the iridium complex transfers to the solid-support and is capable of accelerating the rate determining step; the decomposition of FA into hydrogen and carbon dioxide. The yield of both VA and MMP can be independently tuned depending on the temperature. The simplicity of this approach expands the utility of molecular metal complexes and provides new catalyst opportunities in biorefinery.

Identifiers

PMID35481198
PMCPMC9030846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.